[go: up one dir, main page]

UA85994C2 - N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives - Google Patents

N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives

Info

Publication number
UA85994C2
UA85994C2 UA20040604411A UA20040604411A UA85994C2 UA 85994 C2 UA85994 C2 UA 85994C2 UA 20040604411 A UA20040604411 A UA 20040604411A UA 20040604411 A UA20040604411 A UA 20040604411A UA 85994 C2 UA85994 C2 UA 85994C2
Authority
UA
Ukraine
Prior art keywords
diamino
substituted
hydroxypropane derivatives
hydroxypropane
derivatives
Prior art date
Application number
UA20040604411A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Варгес Джон
Мишель Мейлард
Барбара Ягодзинская
Джеймс П. Бек
Андреа Гейлунас
Ларри Фенг
Дженнифер СИЛИ
Рут Тенбринк
Джон Фрескос
Джон Микельсон
Лаксман Самала
Рой Хом
Original Assignee
Элан Фармасьютикалз, Инк.
Фармациа Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Элан Фармасьютикалз, Инк., Фармациа Энд Апджон Компани filed Critical Элан Фармасьютикалз, Инк.
Publication of UA85994C2 publication Critical patent/UA85994C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Disclosed are compounds of the formula (I), wherein the variables R, R, R, R, R, and Rare as defined herein. These compounds have activity as inhibitors of betasecretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.(І)
UA20040604411A 2001-11-08 2002-11-08 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives UA85994C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33712201P 2001-11-08 2001-11-08

Publications (1)

Publication Number Publication Date
UA85994C2 true UA85994C2 (en) 2009-03-25

Family

ID=35976924

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040604411A UA85994C2 (en) 2001-11-08 2002-11-08 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives

Country Status (3)

Country Link
CN (1) CN1759095A (en)
UA (1) UA85994C2 (en)
ZA (1) ZA200403578B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102344402B (en) * 2010-07-30 2015-01-07 中国人民解放军军事医学科学院毒物药物研究所 Benzoazacyclo hydroxyethylamine compounds, preparation method thereof and purposes thereof
EP3045450B1 (en) * 2010-09-08 2018-02-07 Sumitomo Chemical Co., Ltd. Intermediate compounds in processes for producing pyridazinone compounds
CN110407763B (en) * 2019-08-08 2022-10-14 苏州汉德创宏生化科技有限公司 Synthesis method of 4- (oxazole-2-yl) benzoic acid
CA3177962A1 (en) * 2020-07-31 2022-02-03 Yongmei Xie Multi-efficacy pyrazine compound, preparation method and use thereof

Also Published As

Publication number Publication date
ZA200403578B (en) 2005-10-10
CN1759095A (en) 2006-04-12

Similar Documents

Publication Publication Date Title
RS50504A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
WO2001066564A3 (en) Gamma-secretase inhibitors
BG106585A (en) Kinase inhibitors as therapeutic agents
AU1074702A (en) Sulfamides as gamma-secretase inhibitors
ZA200109995B (en) Nematicidal Trifluorobutenes.
CA2441313A1 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
JO2311B1 (en) Alkyne-aryl phosphodiesterase-4 inhibitors
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
UA84407C2 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
GB9801690D0 (en) Therapeutic agents
MXPA03011006A (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds.
RS53704A (en) Alpha-(n-sulphonamido)acetamide derivatives as betha- amyloid inhibitors
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
MY122696A (en) Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases.
EP1764092A3 (en) Selecting compounds for treatment of Alzheimer's disease
MXPA03006224A (en) Inhibitors of cruzipain and other cysteine proteases.
DE60112330D1 (en) Pyrazolopyridinderivate
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
MXPA04002282A (en) Novel compounds and compositions as cathepsin inhibitors.
MXPA04006041A (en) Pyridoquinoxaline antivirals.
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
AU6339000A (en) Serotonergic benzothiophenes
PT1204659E (en) SEROTONINERGIC BENZOFURANOS